Disappointing 2016 bottom-line vs. a healthy Q1 2017

During Q1 2017, Unimed’s revenues increased by 10.7% to TND16.406m vs. TND14.814m during Q1 2016. This growth is mainly due to a 16.1% progression in pharmaceutical sales to TND5.411m and a 36.6% rise in export outsourcing sales to TND5.016m. Sales to hospitals also increased by 11.3% to TND5.05m vs. TND4.536m as of 31/03/2016. Nevertheless, export revenues were cut in half to reach TND0.89m. The production was up by 5.3% to 50.8 million units.